24 | CytokinesIBA
12/2022
-
06/2013 |
14 | Analgesics (Analgesic Drugs)IBA
02/2023
-
06/2013 |
9 | FlavonoidsIBA
12/2022
-
02/2015 |
6 | Etanercept (Enbrel)FDA Link
09/2021
-
04/2014 |
6 | Peroxidase (Myeloperoxidase)IBA
09/2021
-
07/2014 |
6 | Superoxides (Superoxide)IBA
06/2021
-
12/2015 |
5 | Interleukin-10 (Interleukin 10)IBA
09/2023
-
02/2015 |
5 | Chalcone (Benzalacetophenone)IBA
09/2023
-
02/2015 |
5 | LipopolysaccharidesIBA
12/2022
-
01/2016 |
5 | AntioxidantsIBA
12/2022
-
12/2015 |
5 | CarrageenanIBA
12/2022
-
06/2013 |
5 | Uric Acid (Urate)IBA
01/2022
-
01/2018 |
5 | prolinedithiocarbamate (PDTC)IBA
09/2021
-
06/2016 |
4 | HesperidinIBA
09/2023
-
02/2015 |
4 | Freund's AdjuvantIBA
12/2022
-
06/2013 |
4 | Capsaicin (Zostrix)FDA Link
09/2022
-
06/2013 |
4 | LipidsIBA
01/2022
-
01/2019 |
4 | InflammasomesIBA
12/2019
-
01/2018 |
4 | Messenger RNA (mRNA)IBA
05/2019
-
01/2017 |
3 | kaurenoic acidIBA
02/2023
-
06/2021 |
3 | phenylbenzoquinoneIBA
12/2022
-
06/2013 |
3 | Formaldehyde (Formol)FDA Link
12/2022
-
06/2013 |
3 | Diclofenac (SR 38)FDA LinkGeneric
06/2022
-
06/2017 |
3 | pyrrolidine dithiocarbamic acidIBA
09/2021
-
06/2016 |
3 | Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
09/2021
-
02/2015 |
3 | Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
09/2021
-
07/2014 |
3 | Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021
-
02/2015 |
3 | QuercetinIBA
12/2019
-
01/2016 |
3 | Type I Tumor Necrosis Factor ReceptorsIBA
04/2017
-
04/2014 |
2 | Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2023
-
01/2019 |
2 | Transient Receptor Potential ChannelsIBA
01/2023
-
09/2022 |
2 | titanium dioxide (Titania)FDA Link
01/2023
-
01/2018 |
2 | Opioid Analgesics (Opioids)IBA
09/2022
-
04/2017 |
2 | ZymosanIBA
01/2022
-
12/2019 |
2 | Pentoxifylline (Trental)FDA LinkGeneric
01/2022
-
02/2015 |
2 | 2,2'- azino- di- (3- ethylbenzothiazoline)- 6- sulfonic acid (ABTS)IBA
06/2021
-
06/2018 |
2 | Acetic Acid (Vinegar)FDA LinkGeneric
01/2021
-
02/2015 |
2 | ChemokinesIBA
01/2020
-
05/2019 |
2 | Granulocyte Colony-Stimulating Factor (G-CSF)IBA
12/2019
-
02/2015 |
2 | naringeninIBA
12/2019
-
01/2016 |
2 | Type II Tumor Necrosis Factor ReceptorsIBA
05/2019
-
04/2017 |
2 | vinpocetineIBA
01/2019
-
06/2017 |
2 | Anti-Inflammatory Agents (Anti-Inflammatories)IBA
01/2019
-
09/2018 |
2 | 7,14- dihydroxydocosa- 4,8,10,12,16,19- hexaenoic acidIBA
01/2019
-
01/2019 |
2 | Urea (Carbamide)FDA LinkGeneric
09/2018
-
06/2017 |
2 | CreatinineIBA
09/2018
-
06/2017 |
2 | salicylhydroxamic acid (SHAM)IBA
04/2015
-
07/2014 |
2 | InterleukinsIBA
02/2015
-
07/2014 |
2 | Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
02/2015
-
04/2014 |
1 | lipoxin A4IBA
01/2023 |
1 | Monoclonal AntibodiesIBA
01/2023 |
1 | LipoxinsIBA
01/2023 |
1 | Proteins (Proteins, Gene)FDA Link
01/2023 |
1 | resolvin D5IBA
12/2022 |
1 | FlavonesIBA
12/2022 |
1 | FlavanonesIBA
12/2022 |
1 | AllergensIBA
12/2022 |
1 | ChalconesIBA
12/2022 |
1 | FlavonolsIBA
12/2022 |
1 | Fluo 4IBA
09/2022 |
1 | 3- (4- t- butylphenyl)- N- (2,3- dihydrobenzo(b)(1,4)dioxin- 6- yl)acrylamideIBA
09/2022 |
1 | Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA
09/2022 |
1 | CalciumIBA
09/2022 |
1 | Fluorescent Dyes (Fluorescent Probes)IBA
09/2022 |
1 | Cyclooxygenase InhibitorsIBA
09/2022 |
1 | AntigensIBA
01/2022 |
1 | OvalbuminIBA
01/2022 |
1 | 2,3,4-tri-O-acetylarabinopyranosyl isothiocyanate (AITC)IBA
01/2022 |
1 | LeptinIBA
01/2022 |
1 | NF-kappa B (NF-kB)IBA
09/2021 |
1 | Acetylglucosaminidase (NAGase)IBA
09/2021 |
1 | VenomsIBA
09/2021 |